Results 1 to 10 of about 303 (94)

Emergomyces orientalis Emergomycosis Diagnosed by Metagenomic Next-Generation Sequencing [PDF]

open access: yesEmerging Infectious Diseases, 2021
Emergomyces is a newly described dimorphic fungus genus; it may cause fatal infections in immunocompromised patients, but diagnosis is often delayed. We report a case of disseminated emergomycosis caused by the novel species Emergomyces orientalis in a ...
Fang He, Taoyou Zhou, Xiaoju Lv
exaly   +7 more sources

Disseminated emergomyces orientalis infection in a patient with systemic lupus erythematosus [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
A case of Eimonosis orientalis was reported in a 52-year-old male farmer who presented with cough, phlegm, fever, headache, and nausea for more than 4 days.
Jun Luo, Na An, Yarong Liu, Yisheng Li
exaly   +6 more sources

Morphological and pathogenic investigation of the emerging fungal threat Emergomyces africanus [PDF]

open access: yesMicrobiology Spectrum
Emergomyces africanus is a highly fatal fungal pathogen affecting individuals with advanced HIV disease. Molecular patterns and ultrastructural aspects of E. africanus are unknown, and pathogenic models have not been investigated in detail.
Rafael F Castelli   +2 more
exaly   +6 more sources

Emergomyces pasteurianus in Man Returning to the United States from Liberia and Review of the Literature [PDF]

open access: yesEmerging Infectious Diseases, 2023
A 65-year-old man with HIV sought treatment for fever, weight loss, and productive cough after returning to the United States from Liberia. Fungal cultures grew Emergomyces pasteurianus, and the patient’s health improved after beginning voriconazole. We
Jacob Pierce   +3 more
doaj   +4 more sources

Cavitary nodule caused by Emergomyces orientalis in a diabetic patient: a case report [PDF]

open access: yesFrontiers in Medicine
Emergomyces orientalis is a rare thermally dimorphic fungus belonging to the family Ajellomycetaceae. It exists in the environment as a mold producing conidia, which are inhaled and transform into yeast-like cells at body temperature to cause ...
Yajie Zhou   +7 more
doaj   +3 more sources

Emergomycosis, an Emerging Thermally Dimorphic Fungal Infection: A Systematic Review [PDF]

open access: yesJournal of Fungi, 2023
Emergomycosis is an endemic mycosis caused by the Emergomyces species. Infections due to this agent have been reported globally. Hence, the present systematic review on Emergomyces infections was conducted to study the disease epidemiology, underlying ...
Kalaiselvi Vinayagamoorthy   +3 more
doaj   +2 more sources

Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects [PDF]

open access: yesFrontiers in Medicine, 2021
Recently, the global emergence of emergomycosis, a systemic fungal infection caused by a novel dimorphic fungus Emergomyces species has been observed among immunocompromised individuals.
Arghadip Samaddar, Anuradha Sharma
doaj   +2 more sources

Cbp1, a fungal virulence factor under positive selection, forms an effector complex that drives macrophage lysis. [PDF]

open access: yesPLoS Pathogens, 2022
Intracellular pathogens secrete effectors to manipulate their host cells. Histoplasma capsulatum (Hc) is a fungal intracellular pathogen of humans that grows in a yeast form in the host.
Dinara Azimova   +8 more
doaj   +2 more sources

A presumptive case of cutaneous emergomycosis in a female patient with HIV – Maseru, Lesotho [PDF]

open access: yesSouthern African Journal of Infectious Diseases, 2022
Emergomycosis is a recently described emerging opportunistic fungal infection among individuals living with HIV, in whom it is a cause of significant mortality and morbidity.
Waheeba M.H. Madani, Wayne Grayson
doaj   +2 more sources

Emerging and re-emerging fungal threats in Africa. [PDF]

open access: yesParasite Immunol, 2023
Abstract The emergence of deadly fungal infections in Africa is primarily driven by a disproportionately high burden of human immunodeficiency virus (HIV) infections, lack of access to quality health care, and the unavailability of effective antifungal drugs.
Dangarembizi R, Wasserman S, Hoving JC.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy